SHUKRI MAHALEY: Open Payments
NPI 1821721556 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $215 · 2025 $671
Food & beverage: $572Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $340 |
| GENZYME CORPORATION | 2 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Adaptive Biotechnologies Corporation | 1 | $32 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Tempus AI, Inc | 1 | $15 |
Products named: SARCLISA, CARVYKTI, DARZALEX, TECVAYLI, NINLARO, clonoSEQ, TALVEY, BRUKINSA.
Industry payments across TX — which companies pay providers there.
